Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621969 · ClinicalTrials.gov registry record · NA
Technology Development for Physical Rehabilitation of Patients With Upper Extremity Motor Deficits (RePlay)
A NA study, sponsored by The University of Texas at Dallas.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT03621969 is a NA study that has completed, run by The University of Texas at Dallas. The registered enrollment target is 36 participants.
The verdict
NCT03621969, a NA study, has completed, sponsored by The University of Texas at Dallas.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Injuries and disease processes that produce upper extremity deficits are devastating to patients and their families. One potential avenue to treat these neurological disorders is through the enhancement of neural plasticity, which is the ability of the brain to reorganize and recover following insult. After a minor injury, the brain undergoes beneficial neural plasticity, compensating for altered neural activity to restore normal function. However, in the cases of moderate to severe injury and disease, e.g. spinal cord injury (SCI), insufficient or improper plasticity limits recovery, leaving patients with long-term disability. Therefore, methods that can drive robust and specific plasticity have great potential to treat neurological injuries and disease. The Texas Biomedical Device Center (TXBDC) at UT Dallas has developed a groundbreaking therapy, called Targeted Plasticity Therapy (TPT), which pairs traditional motor, sensory, and cognitive rehabilitation with precise stimulation of the vagus nerve, to guide such robust and specific plasticity to treat a wide range of neurological deficits.
Interventions
- OTHER Physical exam and medical history
- DIAGNOSTIC_TEST Assessments
- DEVICE Patient Instruction and use of Device (RePlay)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621969
The ClinicalTrials.gov registry entry for NCT03621969 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Physical exam and medical history is the first listed.
NCT03621969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621969 about?
NCT03621969 is a clinical study titled "Technology Development for Physical Rehabilitation of Patients With Upper Extremity Motor Deficits (RePlay)". Injuries and disease processes that produce upper extremity deficits are devastating to patients and their families. One potential avenue to treat these neurological disorders is through the enhancement of neural plasticity, which is the ability of the brain to reorganize and recover following insul...
What is the current status of trial NCT03621969?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2017-10-10. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT03621969?
The interventions under investigation include: Physical exam and medical history (OTHER), Assessments (DIAGNOSTIC_TEST), Patient Instruction and use of Device (RePlay) (DEVICE).
Who is sponsoring clinical trial NCT03621969?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.